It helps me.
Thanks for posting it.
I think whole books could be written on this topic.
The discount rate would depend on the investor; it can't be the same for investors with different risk aversions.
Interesting that a curative drug has to be priced very high compared to a drug for a chronic condition.
- Forums
- ASX - By Stock
- XanaHES and its implications for Actinogen
It helps me. Thanks for posting it.I think whole books could be...
Featured News
Add ACW (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
0.010(32.3%) |
Mkt cap ! $110.0M |
Open | High | Low | Value | Volume |
3.3¢ | 4.2¢ | 3.3¢ | $775.2K | 20.62M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1007112 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 96543 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1007112 | 0.040 |
5 | 567512 | 0.039 |
2 | 265000 | 0.037 |
5 | 206002 | 0.036 |
3 | 1384070 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 96543 | 1 |
0.042 | 897999 | 2 |
0.043 | 200000 | 2 |
0.044 | 546941 | 7 |
0.045 | 300000 | 1 |
Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |